DK1198224T3 - Formuleringer til opløsninger af steroider til indgivelse via inhalering - Google Patents
Formuleringer til opløsninger af steroider til indgivelse via inhaleringInfo
- Publication number
- DK1198224T3 DK1198224T3 DK00956216T DK00956216T DK1198224T3 DK 1198224 T3 DK1198224 T3 DK 1198224T3 DK 00956216 T DK00956216 T DK 00956216T DK 00956216 T DK00956216 T DK 00956216T DK 1198224 T3 DK1198224 T3 DK 1198224T3
- Authority
- DK
- Denmark
- Prior art keywords
- formulations
- inhalation administration
- steroid solutions
- relates
- solutions
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 150000003431 steroids Chemical class 0.000 title abstract 2
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1999MI001625A IT1313553B1 (it) | 1999-07-23 | 1999-07-23 | Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione. |
PCT/EP2000/006916 WO2001007014A1 (en) | 1999-07-23 | 2000-07-20 | Formulations of steroid solutions for inhalatory administration |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1198224T3 true DK1198224T3 (da) | 2003-09-29 |
Family
ID=11383393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00956216T DK1198224T3 (da) | 1999-07-23 | 2000-07-20 | Formuleringer til opløsninger af steroider til indgivelse via inhalering |
Country Status (14)
Country | Link |
---|---|
US (1) | US6967017B1 (cs) |
EP (1) | EP1198224B1 (cs) |
AT (1) | ATE241959T1 (cs) |
AU (1) | AU6825000A (cs) |
CZ (1) | CZ299071B6 (cs) |
DE (1) | DE60003183T2 (cs) |
DK (1) | DK1198224T3 (cs) |
ES (1) | ES2200913T3 (cs) |
HU (1) | HUP0201956A3 (cs) |
IT (1) | IT1313553B1 (cs) |
NO (1) | NO20020342L (cs) |
PL (1) | PL198817B1 (cs) |
PT (1) | PT1198224E (cs) |
WO (1) | WO2001007014A1 (cs) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITRM20010614A1 (it) * | 2001-10-16 | 2003-04-16 | Italchimici S P A | Preparazione farmaceutica di una soluzione idro/propilenica di budesonide e suo procedimento di preparazione. |
US20040265238A1 (en) * | 2003-06-27 | 2004-12-30 | Imtiaz Chaudry | Inhalable formulations for treating pulmonary hypertension and methods of using same |
ITMI20032054A1 (it) | 2003-10-22 | 2005-04-23 | Monteres S R L | Processo per la preparazione di sospensioni farmaceutiche da inalare. |
AR041873A1 (es) * | 2003-10-30 | 2005-06-01 | Pablo Cassara Srl Lab | Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante |
PE20050941A1 (es) * | 2003-12-16 | 2005-11-08 | Nycomed Gmbh | Suspensiones acuosas de ciclesonida para nebulizacion |
ITRM20040268A1 (it) * | 2004-05-31 | 2004-08-31 | Italchimici S P A | Formulazione farmaceutica di una soluzione stabile di formoterolo per via inalatoria e suo precedimento di preparazione. |
EA013405B1 (ru) * | 2005-02-25 | 2010-04-30 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Состав аэрозоля для дозирующих ингаляторов под давлением |
GB0604141D0 (en) * | 2006-03-01 | 2006-04-12 | Arrow Int Ltd | Nebulizer formulation |
CZ302596B6 (cs) * | 2007-04-12 | 2011-07-27 | Jihoceská univerzita v Ceských Budejovicích, Zemedelská fakulta | Zpusob zpracování biomasy jetele lucního |
Family Cites Families (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3361306A (en) | 1966-03-31 | 1968-01-02 | Merck & Co Inc | Aerosol unit dispensing uniform amounts of a medically active ingredient |
US3622053A (en) | 1969-12-10 | 1971-11-23 | Schering Corp | Aerosol inhaler with flip-up nozzle |
MX3864E (es) | 1975-05-27 | 1981-08-26 | Syntex Corp | Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona |
US4185100A (en) | 1976-05-13 | 1980-01-22 | Johnson & Johnson | Topical anti-inflammatory drug therapy |
US4499108A (en) | 1983-06-08 | 1985-02-12 | Schering Corporation | Stable pleasant-tasting albuterol sulfate pharmaceutical formulations |
IT1196142B (it) | 1984-06-11 | 1988-11-10 | Sicor Spa | Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti |
US5192528A (en) | 1985-05-22 | 1993-03-09 | Liposome Technology, Inc. | Corticosteroid inhalation treatment method |
GB8828477D0 (en) | 1988-12-06 | 1989-01-05 | Riker Laboratories Inc | Medical aerosol formulations |
US5225183A (en) | 1988-12-06 | 1993-07-06 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
IE67185B1 (en) | 1990-02-02 | 1996-03-06 | Fisons Plc | Propellant compositions |
WO1992011236A1 (en) | 1990-12-19 | 1992-07-09 | Smithkline Beecham Corporation | Aerosol formulations |
US6006745A (en) | 1990-12-21 | 1999-12-28 | Minnesota Mining And Manufacturing Company | Device for delivering an aerosol |
EP0504112A3 (en) | 1991-03-14 | 1993-04-21 | Ciba-Geigy Ag | Pharmaceutical aerosol formulations |
DE69227189T2 (de) | 1991-05-21 | 1999-02-25 | Abbott Laboratories, Abbott Park, Ill. | Aerosolinhalationsvorrichtung |
WO1993004718A1 (de) | 1991-08-29 | 1993-03-18 | Sroka, Peter-Christian | Medizinisches gerät zur inhalation von dosier-aerosolen |
IL103238A (en) | 1991-09-25 | 1995-07-31 | Fisons Plc | Pressurised aerosol compositions |
IL104068A (en) | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant |
ATE204743T1 (de) | 1991-12-18 | 2001-09-15 | Minnesota Mining & Mfg | Aerosolzusammensetzungen für arzneimittelsuspensionen |
DE4230876A1 (de) | 1992-03-17 | 1993-09-23 | Asta Medica Ag | Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten |
RU2126248C1 (ru) | 1992-12-09 | 1999-02-20 | Берингер Ингельхейм Фармасьютикалз, Инк. | Жидкая фармацевтическая композиция в форме аэрозоля |
SE9203743D0 (sv) | 1992-12-11 | 1992-12-11 | Astra Ab | Efficient use |
AU4066693A (en) | 1992-12-23 | 1994-07-19 | Bernhard Hugemann | Compacted drug body for use in the mechanical generation of inhalable active-substance particles |
JPH08507792A (ja) | 1993-03-17 | 1996-08-20 | ミネソタ マイニング アンド マニュファクチャリング カンパニー | ジオール−二酸から誘導される分散助剤を含むエーロゾル配合物 |
ES2122261T3 (es) | 1993-03-17 | 1998-12-16 | Minnesota Mining & Mfg | Formulacion de aerosol que contiene un adyuvante de dispersion derivado de un ester, una amida o un mercaptoester. |
US6596260B1 (en) | 1993-08-27 | 2003-07-22 | Novartis Corporation | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
ES2145254T3 (es) | 1993-12-20 | 2000-07-01 | Minnesota Mining & Mfg | Formulaciones de aerosoles que contienen flunisolida. |
GB9425160D0 (en) | 1994-12-10 | 1995-02-08 | Glaxo Group Ltd | Medicaments |
MY131733A (en) | 1994-12-22 | 2007-08-30 | Astra Ab | Aerosol drug formulations |
GB9426252D0 (en) | 1994-12-24 | 1995-02-22 | Glaxo Group Ltd | Pharmaceutical composition |
DE4446891A1 (de) | 1994-12-27 | 1996-07-04 | Falk Pharma Gmbh | Stabile wäßrige Budesonid-Lösung |
US5653961A (en) | 1995-03-31 | 1997-08-05 | Minnesota Mining And Manufacturing Company | Butixocort aerosol formulations in hydrofluorocarbon propellant |
NZ305787A (en) | 1995-04-14 | 1999-07-29 | Glaxo Wellcome Inc | Metered dose inhaler for fluticasone propionate |
WO1996032099A1 (en) | 1995-04-14 | 1996-10-17 | Glaxo Wellcome Inc. | Metered dose inhaler for albuterol |
NZ306280A (en) | 1995-04-14 | 1999-07-29 | Glaxo Wellcome Inc | Metered dose inhaler for salmeterol |
ATE258813T1 (de) | 1995-04-14 | 2004-02-15 | Smithkline Beecham Corp | Vorrichtung zur dosierten inhalierung von beclomethason-diproprionat |
GB9612297D0 (en) | 1996-06-11 | 1996-08-14 | Minnesota Mining & Mfg | Medicinal aerosol formulations |
JP2000514085A (ja) | 1996-07-08 | 2000-10-24 | ローヌ―プーラン・ロウラー・リミテッド | 医薬シクロスポリンaエーロゾル溶液処方物 |
AU3811897A (en) | 1996-07-24 | 1998-02-10 | Oglios Therapeutics, Inc. | Antisense oligonucleotides as antibacterial agents |
GB9616237D0 (en) | 1996-08-01 | 1996-09-11 | Norton Healthcare Ltd | Aerosol formulations |
GB9620187D0 (en) | 1996-09-27 | 1996-11-13 | Minnesota Mining & Mfg | Medicinal aerosol formulations |
ATE301991T1 (de) | 1996-12-04 | 2005-09-15 | Link Products Ltd | Arzneimittel zusammensetzungen und vorrichtungen zu deren verabreichung |
US6413496B1 (en) | 1996-12-04 | 2002-07-02 | Biogland Ireland (R&D) Limited | Pharmaceutical compositions and devices for their administration |
DK1014943T3 (da) | 1997-02-05 | 2002-10-14 | Jago Res Ag | Medicinske aerosolformuleringer |
US6126919A (en) | 1997-02-07 | 2000-10-03 | 3M Innovative Properties Company | Biocompatible compounds for pharmaceutical drug delivery systems |
US5891419A (en) | 1997-04-21 | 1999-04-06 | Aeropharm Technology Limited | Environmentally safe flunisolide aerosol formulations for oral inhalation |
GB2326334A (en) | 1997-06-13 | 1998-12-23 | Chiesi Farma Spa | Pharmaceutical aerosol compositions |
US20010031244A1 (en) | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
BR7702049U (pt) | 1997-09-05 | 1999-09-14 | Chiesi Farma Spa | Bico pulverizador para utilização em inalador oral para medicamentos aerossóis |
NZ504021A (en) | 1997-10-17 | 2003-04-29 | Systemic Pulmonary Delivery Lt | Method and apparatus for delivering aerosolized medication having air discharged through air tube directly into plume of aerosolized medication |
US6045784A (en) | 1998-05-07 | 2000-04-04 | The Procter & Gamble Company | Aerosol package compositions containing fluorinated hydrocarbon propellants |
SE9802073D0 (sv) | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
ID27554A (id) | 1998-06-18 | 2001-04-12 | Boehringer Ingelheim Pharma | Formulasi-formulasi sediaan farmasi untuk aerosol dengan dua atau lebih bahan aktif |
US6451285B2 (en) | 1998-06-19 | 2002-09-17 | Baker Norton Pharmaceuticals, Inc. | Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant |
US6241969B1 (en) * | 1998-06-26 | 2001-06-05 | Elan Corporation Plc | Aqueous compositions containing corticosteroids for nasal and pulmonary delivery |
DE59911149D1 (de) | 1998-07-24 | 2004-12-30 | Jago Res Ag Muttenz | Medizinische aerosolformulierungen |
EP1102579B1 (de) | 1998-08-04 | 2003-03-19 | Jago Research Ag | Medizinische aerosolformulierungen |
DE19847969A1 (de) | 1998-10-17 | 2000-04-20 | Boehringer Ingelheim Pharma | Lagerfähig flüssige Formulierung mit Formoterol |
WO2000023065A2 (de) | 1998-10-17 | 2000-04-27 | Boehringer Ingelheim Pharma Kg | Lagerfähiges wirkstoffkonzentrat mit formoterol |
RU2221552C2 (ru) | 1998-11-13 | 2004-01-20 | Джаго Рисерч Аг | Сухой порошок для ингаляции |
DZ2947A1 (fr) | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
IT1303788B1 (it) | 1998-11-25 | 2001-02-23 | Chiesi Farma Spa | Formulazioni di aerosol medicinali. |
US6290930B1 (en) | 1998-12-18 | 2001-09-18 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide |
US6004537A (en) * | 1998-12-18 | 1999-12-21 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol |
WO2000053157A1 (en) | 1999-03-05 | 2000-09-14 | Chiesi Farmaceutici S.P.A. | Improved powdery pharmaceutical compositions for inhalation |
US6315985B1 (en) | 1999-06-18 | 2001-11-13 | 3M Innovative Properties Company | C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability |
DE60019167T2 (de) | 1999-12-24 | 2006-05-11 | Glaxo Group Ltd., Greenford | Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason |
IT1317846B1 (it) | 2000-02-22 | 2003-07-15 | Chiesi Farma Spa | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. |
IT1318514B1 (it) | 2000-05-12 | 2003-08-27 | Chiesi Farma Spa | Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari. |
WO2001089480A1 (en) | 2000-05-22 | 2001-11-29 | Chiesi Farmaceutici S.P.A. | Stable pharmaceutical solution formulations for pressurised metered dose inhalers |
-
1999
- 1999-07-23 IT IT1999MI001625A patent/IT1313553B1/it active
-
2000
- 2000-07-20 DE DE60003183T patent/DE60003183T2/de not_active Expired - Lifetime
- 2000-07-20 HU HU0201956A patent/HUP0201956A3/hu unknown
- 2000-07-20 DK DK00956216T patent/DK1198224T3/da active
- 2000-07-20 CZ CZ20020257A patent/CZ299071B6/cs not_active IP Right Cessation
- 2000-07-20 AU AU68250/00A patent/AU6825000A/en not_active Abandoned
- 2000-07-20 AT AT00956216T patent/ATE241959T1/de active
- 2000-07-20 WO PCT/EP2000/006916 patent/WO2001007014A1/en active IP Right Grant
- 2000-07-20 PT PT00956216T patent/PT1198224E/pt unknown
- 2000-07-20 US US10/030,101 patent/US6967017B1/en not_active Expired - Fee Related
- 2000-07-20 EP EP00956216A patent/EP1198224B1/en not_active Expired - Lifetime
- 2000-07-20 ES ES00956216T patent/ES2200913T3/es not_active Expired - Lifetime
- 2000-07-20 PL PL353470A patent/PL198817B1/pl unknown
-
2002
- 2002-01-22 NO NO20020342A patent/NO20020342L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PL353470A1 (en) | 2003-11-17 |
HUP0201956A2 (en) | 2002-10-28 |
PT1198224E (pt) | 2003-10-31 |
EP1198224A1 (en) | 2002-04-24 |
EP1198224B1 (en) | 2003-06-04 |
NO20020342D0 (no) | 2002-01-22 |
CZ2002257A3 (cs) | 2002-05-15 |
ITMI991625A1 (it) | 2001-01-23 |
IT1313553B1 (it) | 2002-09-09 |
AU6825000A (en) | 2001-02-13 |
NO20020342L (no) | 2002-01-22 |
WO2001007014A1 (en) | 2001-02-01 |
HUP0201956A3 (en) | 2003-10-28 |
US6967017B1 (en) | 2005-11-22 |
DE60003183D1 (de) | 2003-07-10 |
CZ299071B6 (cs) | 2008-04-16 |
ATE241959T1 (de) | 2003-06-15 |
ES2200913T3 (es) | 2004-03-16 |
PL198817B1 (pl) | 2008-07-31 |
ITMI991625A0 (it) | 1999-07-23 |
DE60003183T2 (de) | 2004-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005065185A3 (en) | Temperature-stable formulations, and methods of development thereof | |
JP4603687B2 (ja) | 点鼻用液剤 | |
WO2002011711A3 (en) | Formulations of mometasone and a bronchodilator for pulmonary administration | |
WO2005004895A3 (en) | Compositions and methods for enhanced mucosal delivery of growth hormone | |
RU94040387A (ru) | Композиция, способствующая прекращению курения, никотиносодержащий распыляемый раствор, способ снижения потребности в курении табака, способ замены курения табака | |
DE60120648D1 (de) | Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung | |
TW200616650A (en) | Semi-solid delivery vehicle and pharmaceutical compositions | |
SE0102276D0 (sv) | Device and method for the administration of a medicament | |
AU2001296865A1 (en) | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents | |
WO2005044226A3 (en) | Lipid formulations for spontaneous drug encapsulation | |
AU2001288460A1 (en) | Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant | |
WO2003079993A3 (en) | hGH (HUMAN GROWTH HORMONE) FORMULATIONS FOR PULMONARY ADMINISTRATION | |
DK1198224T3 (da) | Formuleringer til opløsninger af steroider til indgivelse via inhalering | |
MA27702A1 (fr) | Preparation de suspensions aqueuses steriles comprenant des ingredients actifs cristallins micronises, destinees a l'inhalation | |
DK1280558T3 (da) | Halvfast indgivelsesvehikel og farmaceutiske sammensætninger | |
NO20023875L (no) | Stabilt nasalt, oralt eller sublingualt anvendbart preparat | |
WO2001047913A3 (de) | Substituierte n-benzyl-indol-3-yl- glyoxylsäure-derivate antitumorwirkung | |
ATE350024T1 (de) | Flüssige zubereitung enthaltend tobramycin | |
ATE311928T1 (de) | (-)-pseudoephedrin als sympathomimetisches arzneimittel | |
PT1343472E (pt) | Pulverizacao nasal tixotropica | |
NZ537186A (en) | Nasal compositions comprising a mucopolysaccharide and propylene glycol | |
JPH11147825A (ja) | 粘膜吸収性の向上方法及び粘膜外用剤 | |
Bose et al. | Lidocaine in bronchoscopy: Practical use and allergic reactions | |
NO20013605D0 (no) | Preparat for vorter | |
WO2004033484A3 (en) | Use of stable glutamine derivatives to improve drug absorption |